Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
In October 2025, distributors and retailers focused on liquidating higher-priced inventory, and post-trade stabilisation helped improve consumer sentiment across urban and rural markets. Rural demand continued to outperform urban areas during the quarter.
Within the domestic business, the Home & Personal Care segment is expected to deliver double-digit growth, driven by strong performance in Hair Oils and Oral Care categories. Key brands likely to lead volume growth include Dabur Amla, Dabur Almond, Dabur Anmol, Dabur Red Toothpaste, and Meswak. Most of the portfolio is expected to outperform category growth, supporting market share gains in several categories.
The Healthcare segment is projected to see sequential improvement, supported by nearly 10% growth in Dabur Honey and 15%+ YoY growth in Honitus and Health Juices. Hajmola and the Ethicals portfolio are likely to post mid-single digit growth. While primary sales of Dabur Chyawanprash may remain muted, secondary sales remain positive, with momentum expected to strengthen in January 2026 due to an extended winter. Overall, the Healthcare segment is expected to report low-single digit growth.
In Food & Beverages, the Culinary business is expected to achieve double-digit growth. The Beverages portfolio, particularly Nectars & Drinks, may see muted performance due to seasonality, but the premium ‘Real Activ’ range is performing strongly, with 100% Activ juices and Coconut Water expected to grow 30%+, registering market share gains and reinforcing the brand’s premium positioning.
On the distribution and sales channels front, organised trade continues to maintain strong growth momentum. E-commerce, including Quick Commerce, is expected to deliver robust double-digit growth, reflecting increasing online penetration in both urban and semi-urban markets.
The international business performed well in key geographies such as MENA, Turkey, Namaste, and Bangladesh, supporting near double-digit growth in INR terms.
Overall, Dabur India expects consolidated revenue to grow in mid-single digits, with operating profit and net profit projected to outpace revenue growth. The company said that favourable macroeconomic conditions, GST rate revisions, and recent tax reforms are expected to support a sustained recovery in consumer demand and improve revenue trajectory in the coming quarters.
Dabur is India’s leading FMCG, Ayurvedic and natural health care companies with wide network distribution across world.
Shares of Dabur India shed 0.50% to currently trade at Rs 518.60 on the BSE.
Dabur India Ltd is up for a third straight session in a row. The stock is quoting at Rs 506.1, up 2.11% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.76% on the day, quoting at 26136.25. The Sensex is at 85259.33, up 0.69%. Dabur India Ltd has dropped around 1.78% in last one month.
Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has dropped around 0.07% in last one month and is currently quoting at 55033.15, up 0.92% on the day. The volume in the stock stood at 14.42 lakh shares today, compared to the daily average of 12.4 lakh shares in last one month.
The benchmark January futures contract for the stock is quoting at Rs 509.05, up 2.12% on the day. Dabur India Ltd is down 0.95% in last one year as compared to a 10.08% gain in NIFTY and a 2.59% gain in the Nifty FMCG index.
The PE of the stock is 61.72 based on TTM earnings ending September 25.
Dabur India Ltd dropped for a fifth straight session today. The stock is quoting at Rs 487.25, down 0.19% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.36% on the day, quoting at 25948.55. The Sensex is at 84699.55, down 0.4%.Dabur India Ltd has lost around 5.43% in last one month.Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has eased around 0.77% in last one month and is currently quoting at 55132.05, down 0.1% on the day. The volume in the stock stood at 6.34 lakh shares today, compared to the daily average of 12.02 lakh shares in last one month.
The benchmark December futures contract for the stock is quoting at Rs 489.95, up 0.01% on the day. Dabur India Ltd tumbled 3.56% in last one year as compared to a 9.74% rally in NIFTY and a 2.73% fall in the Nifty FMCG index.
The PE of the stock is 60.83 based on TTM earnings ending September 25.
Dabur India Ltd dropped for a fifth straight session today. The stock is quoting at Rs 496.3, down 1.09% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.5% on the day, quoting at 26028.95. The Sensex is at 85234.87, up 0.49%.Dabur India Ltd has lost around 4.96% in last one month.Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has eased around 1.55% in last one month and is currently quoting at 54619.65, down 0.43% on the day. The volume in the stock stood at 6.68 lakh shares today, compared to the daily average of 18.89 lakh shares in last one month.
The benchmark December futures contract for the stock is quoting at Rs 496.35, down 1.38% on the day. Dabur India Ltd tumbled 3.22% in last one year as compared to a 5.09% rally in NIFTY and a 4.37% fall in the Nifty FMCG index.
The PE of the stock is 62.53 based on TTM earnings ending September 25.
Dabur India Ltd is up for a third straight session today. The stock is quoting at Rs 528.1, up 1.11% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.3% on the day, quoting at 25952.55. The Sensex is at 84734.14, up 0.32%. Dabur India Ltd has gained around 8.36% in last one month.
Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has gained around 2.42% in last one month and is currently quoting at 55529.2, down 0% on the day. The volume in the stock stood at 10.06 lakh shares today, compared to the daily average of 26 lakh shares in last one month.
The benchmark November futures contract for the stock is quoting at Rs 527.55, up 0.57% on the day. Dabur India Ltd is up 3.94% in last one year as compared to a 10.28% jump in NIFTY and a 0.46% jump in the Nifty FMCG index.
The PE of the stock is 65.02 based on TTM earnings ending September 25.
Revenue from operations was at Rs 3,191.32 crore in the second quarter of FY26, up 5.37% year on year.
Profit before tax stood at Rs 573.02 crore in Q2 FY26, up 4.95% as against Rs 545.96 crore posted in Q2 FY25.
Dabur India's total expenses were at Rs 2,758.33 crore, up 4.70% in the September 2025 quarter from Rs 2,634.40 crore in the year ago period.
Dabur India reported steady growth across major verticals, including health supplements, toothpaste, hair care, skin care, and home care, during the second quarter.
The toothpaste segment led the performance with a 14.3% year-on-year growth, driven by strong demand for dabur red paste and the premium brand Meswak. The company’s 100% fruit juice portfolio under the real activ brand surged over 45%, while the overall foods portfolio grew by more than 14%.
In the personal care segment, shampoo sales rose over 9%, and the hair oils business expanded by more than 5%. The skin & salon portfolio grew around 8%, while home care recorded over 5% growth during the quarter.
Dabur also gained market share across several key categories. Real Nectars gained 115 basis points (bps), the 100% Juices portfolio reported a 1,074-bps improvement, hair oils gained 232 bps, chyawanprash expanded by 234 bps, and air fresheners added 127 bps in market share.
Dabur’s international business delivered a robust 7.7% year-on-year growth in the second quarter, driven by strong performances across key geographies.
The company reported over 17% growth in Dubai, while the UK business surged around 48%. In Bangladesh and the US, revenues grew by approximately 16% each, and Turkey posted an impressive 18% growth during the quarter.
Dabur said this performance reflects its agility in navigating global challenges while staying true to its Ayurvedic heritage and innovation-led strategy.
Dabur India’s board has approved the launch of Dabur Ventures, a new investment platform with a capital allocation of up to Rs 500 crore.
The initiative will be fully funded through Dabur’s balance sheet and will focus on investing in high-potential, new-age digital-first businesses that exhibit strong growth potential.
The company said the move aligns with its long-term strategic vision of expanding into emerging consumer categories and strengthening its digital and innovation-led growth ecosystem.
Mohit Mathotra, chief executive officer, Dabur lndia, said, 'Our performance during the quarter stands as a testament to Dabur's enduring resilience and consumer trust. Despite a dynamic economic environment and transitional GST headwinds, we delivered robust topline and bottomline growth, reaffirming our leadership across core categories. Our India business reported market share gains across 95% of the portfolio, a clear testament to our focused brand investments and deep consumer connect.
We are entering a new phase of growth, powered by a future-ready strategy and deep consumer trust. We are investing boldly in premiumization, digital transformation, and distribution expansion, three pillars that will define the next chapter of our journey. As macroeconomic indicators turn favorable and GST reforms unlock afford ability, Dabur is uniquely positioned to accelerate inclusive growth and reinforce its leadership across segments.
Our approach will be to invest in new-age future forward businesses in the spaces of Personal Care, Health Care, Wellness Foods, Beverages, and Ayurveda. This initiative underscores our commitment to innovation-Led growth, while accelerating our premiumisation journey and opening doors to emerging consumer spaces that define the future of our industry.'
Meanwhile, the board of directors of Dabur India has approved an interim dividend of 275% for the financial year 2025-26. The dividend amounts to Rs 2.75 per share, translating to a total payout of Rs 487.76 crore, in line with the company’s consistent shareholder return policy.
Shares of Dabur India fell 2.11% to Rs 490.75 on the BSE.